Screening
Description:
The NM ASSIST is a screening tool that can be used in primary care to detect drug and alcohol abuse. The full version of the tool includes step-by-step screening algorithms.
Source:
NIDA
Description:
The NIDA Quick Screen can be used in clinical practice to screen patients for substance use disorders.
Source:
NIDA (1 vote)
Description:
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides this website so that physicians can improve the deliver and financing of prevention, treatment and recovery support services to patients.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Tags:
- General information - opioid addiction
- General information - buprenorphine
- Screening and diagnosis
- Induction and dosing
- Rules, regulations and recordkeeping
- Physician and staff training
- Addiction
- Adolescents
- Dependence
- Pharmacotherapy
- Screening
- Side effects
- Tolerance
- Withdrawal
- Misc. informational materials
- Patient education materials
- Becoming waivered
- Experienced prescriber
- Just became waivered
- Need to refer
- Setting up a practice
Description:
The California Society of Addiction Medicine (CSAM) website provides information and materials for buprenorphine treatment providers, including screening tools and sample consent and patient agreement forms, and provides links to other helpful resources.
Source:
California Society of Addiction Medicine (CSAM)
Tags:
- General information - buprenorphine
- Getting a waiver/setting up your practice
- Initial patient contact
- Screening and diagnosis
- Rules, regulations and recordkeeping
- Physician and staff training
- Addiction
- Assessment
- Confidentiality
- Consent
- Contract
- COWS
- Recordkeeping
- Screening
- Training
- Waiver
- Misc. informational materials
- Becoming waivered
- Just became waivered
- Need to refer
- Setting up a practice
Description:
Developed by a consensus panel, these guidelines provide treatment recommendations for patients with dual disorders.
Source:
U.S. Department of Health and Human Services, SAMHSA
Tags:
- Screening and diagnosis
- Special populations
- Managing challenging patients
- Addiction
- Assessment
- Behavioral therapy
- Comorbidities
- Complicated patients
- Dependence
- Drug interactions
- Expert panel
- Pharmacology
- Pharmacotherapy
- Pharmacy
- Polysubstance use
- Psychiatric
- Psychosocial
- Referral
- Relapse
- Risk factors
- Screening
- Side effects
- Special populations
- Symptoms
- Tolerance
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
- Need to refer
Description:
This information brief discusses the abuse of prescription drugs by young people, commonly abused prescription drugs, and diversion of said drugs.
Source:
National Drug Intelligence Center
Tags:
Description:
Information on why your patient should be in withdrawal before beginning buprenorphine induction.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) (3 votes)
Tags:
Description:
Offers recommendations for screening and assessment of adolescents as and discusses referrals, legal issues, and the juvenile justice system.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) (4 votes)
Tags:
Description:
A checklist that allows the physician to determine if the patient is in withdrawal in order to administer initial buprenorphine dose.
Source:
American Academy of Addiction Psychiatry (AAAP) (3 votes)
Tags:
Description:
This article reviews the history of opiate withdrawal scales and their use.
Source:
The Journal of Psychoactive Drugs (2 votes)
Tags:
